Envarsus XR 1 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FRQ92
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,107
Award facts
- Contract value 100% obligated
- $3,106.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Envarsus XR 1 mg tablets (30-count supply) valued at $3,106.80, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Envarsus XR is an extended-release formulation of tacrolimus, an immunosuppressant medication commonly used in transplant and autoimmune disease management within military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical supply agreement running through December 2026. As a prime pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp supplies a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide through DLA and the Defense Health Agency. The company's extensive federal contract portfolio demonstrates its capability to fulfill competitive procurement requirements across multiple therapeutic domains and order values.
Quick answers
Who was awarded contract SPE2DB25FRQ92?
SPE2DB25FRQ92 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 25, 2025.
How much is contract SPE2DB25FRQ92 worth?
The government has obligated $3,107 on SPE2DB25FRQ92.
Is contract SPE2DB25FRQ92 an order under another contract?
Yes. SPE2DB25FRQ92 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRQ92 competed?
The extent of competition for SPE2DB25FRQ92 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award